Scaling a hygroscopic, thermolabile tablet from 30 kg to 300 kg
A 300 kg commercial batch of immediate-release tablets contains 45% w/w of a thermolabile, hygroscopic API (melting point about 68 °C, freely water-soluble, hydrolysis-limited t90 of 18 months at 30 °C/65% RH against a 24-month specification). The formula is API 45%, microcrystalline cellulose 40%, croscarmellose sodium 3%, colloidal silicon dioxide 0.5%, magnesium stearate 1%, lactose to 100%. Direct compression was transferred from a 30 kg pilot batch. On the 45-station rotary press the blend (Carr's index 31%, Hausner ratio 1.45) runs acceptably only at 25 rpm; at 40 rpm rejects from capping reach 5%, and sticking on punch faces appears after 20 minutes. Mean crushing strength is 4.2 kp against a target of at least 6 kp. Dissolution at 15 minutes is 83% (specification Q = 80% at 30 minutes). One team member proposes aqueous wet granulation, another roller compaction, and the production head wants to keep direct compression and simply slow the press down.
1. Which manufacturing route would you choose - aqueous wet granulation, roller compaction, or continued direct compression with a modified formula - and why? Address the API's thermal and moisture sensitivity and the dissolution risk of your choice.
Read the worked answer
The decision hinges on the API's two liabilities: it hydrolyses (18-month t90 against a 24-month shelf life) and it melts at about 68 °C, so any process that adds water plus a 60 °C drying step attacks both. Aqueous wet granulation is therefore the wrong first choice, and the water activity of the granules would also raise the rate of hydrolysis during drying and storage. Continuing with direct compression is feasible only if flow is fixed; a Carr's index of 31% (Hausner 1.45) is in the 'very poor' band and is itself a likely contributor to weight variation and to the 5% capping seen when the turret speed is raised to 40 rpm. Simply slowing the press is a workaround, not a fix - it caps output and leaves the flow problem in place.
Roller compaction is the best fit: it is a dry process (no water, no solvent, no high-temperature drying), it densifies the blend enough to fix flow, and it can be run below the API's melting point. Two safeguards must be built in. First, control roll force and gap so that ribbon solid fraction stays around 0.65-0.70; over-compaction will close the pores and push the already borderline dissolution (83% at 15 minutes) further down. Second, keep roll and mill temperature below about 40 °C and mill to a specified particle size. Compare the new granulation against the current blend by dissolution profile (f2 greater than 50) and by accelerated stability before committing the 300 kg scale.
2. Explain the mechanism linking magnesium stearate, blending and capping, and propose numeric in-process controls you would justify to a reviewer.
Read the worked answer
Magnesium stearate is a hydrophobic, lamellar powder. Under shear it smears into films over particle surfaces; the longer and more intense the blending, the greater the surface coverage and the lower the interparticulate bonding available at compaction. The consequences are exactly what is seen: crushing strength only 4.2 kp against a target of 6 kp, and capping when turret speed rises, because at 40 rpm the dwell time is shorter and air in the die has less time to escape from a weakly bonded compact. A 1% level is at the top of the usual direct-compression range and, combined with a blend that already flows poorly, leaves no margin.
Controls to propose and defend: reduce magnesium stearate to 0.5% w/w; add it last and limit total lubrication to 2-3 minutes at low shear speed, with the time recorded in the batch record and validated; include a pre-compression roller setting (5-10 kN) and a tapered die to de-aerate; cap turret speed at 30 rpm and document the resulting dwell time. Demonstrate lubricant sensitivity by compressing samples after 0, 2 and 4 hours of continuous blending and measuring crushing strength and capping tendency - that experiment, not an opinion, is what a reviewer will accept as justification for the time limit. Sticking on punch faces is consistent with frictional heating of a low-melting API; colloidal silicon dioxide up to 1%, polished or chrome-plated punches and reduced speed are the first-line countermeasures.
3. Sticking appears on the punch faces and the 18-month t90 falls short of the 24-month target. Propose formulation and packaging countermeasures and the stability protocol that would confirm them.
Read the worked answer
Sticking and the short t90 need separate answers, because one is a surface problem and the other is a moisture problem. For sticking: keep granule moisture below about 2% (loss on drying), add colloidal silicon dioxide up to 1% as glidant/anti-adherent, reduce turret speed so punch-face temperature stays low, and specify punch polishing at defined intervals rather than when the operator notices.
For stability, hydrolysis rate is set by water activity in the tablet and by moisture ingress through the pack, so the primary countermeasure is packaging rather than another excipient. A cold-form aluminium-aluminium blister gives a moisture transmission rate low enough to hold water content at 1-2% through shelf life; PVC/PVDC is cheaper but usually inadequate for a hydrolysis-limited, hygroscopic product. Confirm with a protocol run to ICH Q1A conditions: 30 °C/75% RH long term (Zone IVb) for 24 months with points at 3, 6, 9, 12, 18 and 24 months; 40 °C/75% RH accelerated for 6 months at 0, 3 and 6 months; a moisture-stress arm at 25 °C/80% RH; and a photostability study. Test at each point: assay and specified degradants by a stability-indicating HPLC method, water content by Karl Fischer, dissolution, hardness, appearance and microbial limits. Set assay at not less than 95% of label and degradant limits against ICH Q3B thresholds for the maximum daily dose. The pack is justified only if the 24-month data, or accelerated data with a defensible extrapolation, meet specification.